Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Colgate-Palmolive Company (CL) SEC Filings & Earnings Calls

EquiReason read 13 Colgate-Palmolive Company SEC filings in the last 12 months. Latest: 10-Q on 2026-07-31 — Colgate-Palmolive reported Q2 2026 results with net sales up 4.9% YoY, but GAAP net income down 6.7% due to $129M restructuring charges; non-GAAP EPS up 8%..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CLColgate-Palmolive CompanyFollow CL — free
Household & Personal Products · Consumer Defensive
—
Price chart with a free account
Market cap
75.0B
P/E TTM
37.2
Dividend yield
2.2%
52-week
—
Next earnings
30 Oct, in 6 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

31 Jul 202610-QColgate-Palmolive reported Q2 2026 results with net sales up 4.9% YoY, but GAAP net income down 6.7% due to $129M restructuring charges; non-GAAP EPS up 8%.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q2-2026$5.36B+5% y/y
Net income attributable to Colgate-Palmolive Company · Q2-2026$693M-7% y/y
Diluted earnings per share · Q2-2026$0.86-6% y/y
Gross profit margin · Q2-202661.5%
Organic sales growth · Q2-20262.4%
Operating profit · Q2-2026$1.02B-6% y/y
Operating cash flow · H1-2026$1.74B+17% y/y

Guidance

Full year effective tax rate estimated at 23.6%; capital expenditures expected ~3.0% of sales

Management expects continued softness across categories through H2 2026, but remains confident in 2030 strategy and restructuring program to drive long-term growth.

Risks flagged

Restructuring Execution Risk

“The Strategic Growth and Productivity Program is estimated to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $350 and $550.” · word for word

Talcum Powder Litigation

“As of June 30, 2026, there were 525 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 484 cases as of March 31, 2026 and 453 cases as of December 31, 2025.” · word for word

Tariff and Trade Policy Risk

“Major developments in trade relations, including the imposition of new or increased tariffs by the United States and/or other countries, have contributed to and are expected to continue to contribute to inflationary pressures, geopolitical tensions and macroeconomic and market volatility.” · word for word
Read the original on SEC EDGAR ↗
31 Jul 20268-K · 2.02Net Sales $5.36B (+5% y/y); Organic Sales Growth 2.4; GAAP EPS (diluted) $0.86 (-5% y/y); Guidance: Base Business EPS growth raised to mid-single-digit from low- to mid-single-digit; gross margin outlook improved to roughly flat from downearningsopen

Figures in the filing · each found in the filing text

Net Sales · Q2-2026$5.36B+5% y/y
Organic Sales Growth · Q2-20262.4%
GAAP EPS (diluted) · Q2-2026$0.86-5% y/y
Base Business EPS (diluted) · Q2-2026$0.99+8% y/y
GAAP Gross Profit Margin · Q2-202661.5%
Net cash provided by operations · H1-2026$1.74B
Global market share in toothpaste · YTD-202641.3%
Global market share in manual toothbrushes · YTD-202632.7%

Guidance

Base Business EPS growth raised to mid-single-digit from low- to mid-single-digit; gross margin outlook improved to roughly flat from down

Colgate raised Base Business EPS guidance and improved gross margin outlook, while maintaining net sales and organic sales guidance. Management expressed confidence in delivering consistent earnings growth.

Risks flagged

North America sales decline due to private label pet food exit and volume drop.

“North America net sales -3.0%, organic sales -3.0%, volume -3.9%”

Volatile market conditions expected to continue in balance of 2026.

“While we expect the volatile market conditions to continue in the balance of 2026” · word for word
Read the original on SEC EDGAR ↗
1 May 20268-K · 2.02, 2.05Released earnings results and quarterly financials; approved costs associated with restructuring, layoffs, or exit activitiesearningsopen

Risks flagged

Restructuring charges may impact near-term earnings and cash flow.

“Item 2.05: estimated 80% to 90% of charges will result in cash expenditures.”
Read the original on SEC EDGAR ↗
1 May 202610-QNet sales $5.32B (+8% y/y); Organic sales growth 2.9; Gross profit margin 60.6; Guidance: Capex expected ~3.0% of net sales for 2026open

Figures in the filing · each found in the filing text

Net sales · Q1-2026$5.32B+8% y/y
Organic sales growth · Q1-20262.9%
Gross profit margin · Q1-202660.6%
Non-GAAP operating profit margin · Q1-202621.3%
Non-GAAP diluted EPS · Q1-2026$0.97+7% y/y
Net cash provided by operations · Q1-2026$747M+25% y/y
Global toothpaste market share · Oral Care · YTD-202641.1%
Global manual toothbrush market share · Oral Care · YTD-202632.6%
Advertising investment · Q1-2026$734M+10% y/y
Capital expenditures · Q1-2026$138M+11% y/y

Guidance

Capex expected ~3.0% of net sales for 2026

No explicit quantitative revenue or EPS guidance. Capex expected ~3% of net sales. Management expresses confidence in 2030 strategy and restructuring program.

Risks flagged

Tariff-driven raw material cost inflation

“significantly higher raw and packaging material costs (350 bps), which included the impact of tariffs” · word for word

North America organic sales decline

“Organic sales in North America decreased 2.2% in the first quarter of 2026.” · word for word

Restructuring execution risk

“Strategic Growth and Productivity Program... estimated to result in cumulative pre-tax charges... totaling between $350 and $550”
Read the original on SEC EDGAR ↗
9 Apr 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Loss of experienced Chief Legal Officer; transition risk mitigated by internal promotion and phased transition.

“Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary ... since 2014, has communicated ... her intention to retire ... the Board elected Betsy Fishbone ... to the position of Chief Legal Officer and Secretary, effective June 1, 2026.” · word for word
Read the original on SEC EDGAR ↗
25 Mar 2026DEF 14AProxy statement filed for 2026 annual meeting, detailing executive compensation structure and governance practices.open

Figures in the filing · each found in the filing text

Net Sales · FY2025$20.40B
Organic Sales Growth · FY20251.4%
Base Business Earnings Per Share · FY2025$3.69
Free Cash Flow Productivity · 2023-2025115.7%
Net Income · FY2025$2.26B
Total Shareholder Return (1-year) · FY2025$104.00
Dividend Payments (consecutive years) · FY2025131
Dividend Increases (consecutive years) · FY202563
Capital Returned to Shareholders · FY2025$2.90B
CEO Target Direct Compensation (Long-Term Incentives) · FY2025$12M+8% y/y

Risks flagged

Tariff impact on earnings and guidance

“the P&O Committee specifically reserved the right to adjust the calculation of the performance measures for extraordinary events, including the possible positive or negative impact of tariffs not yet announced when the targets were set.” · word for word

Slowing organic sales growth

“our organic sales growth slowed considerably and our Base Business Earnings Per Share also grew at a slower rate.” · word for word

Macroeconomic and geopolitical volatility

“2025 was a challenging year, as global macroeconomic and geopolitical volatility, slower global category growth rates, consumer uncertainty, tariffs and high raw material inflation impacted sales and profit growth across the consumer sector.” · word for word

Raw material inflation

“high raw material inflation impacted sales and profit growth across the consumer sector.” · word for word

Consumer uncertainty and trading down

“Colgate-Palmolive noted a persistently cautious consumer environment in North America, with inflation driving some consumers to switch from premium products to cheaper private-label brands.” · word for word
Read the original on SEC EDGAR ↗
17 Mar 20268-K · 8.01Colgate-Palmolive Company realigned its reportable operating segments effective Q1 2026, combining Europe and Africa/Eurasia (ex-Russia/Belarus) and Skin Health into a new Europe, Middle East and Africa segment. Russia/Belarus moved to Asiaopen

Risks flagged

No new risks identified; segment change is administrative.

“No impact on financials.”
Read the original on SEC EDGAR ↗
12 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
23 Feb 202610-KNet sales - Oral Care 44; Net sales - Personal Care 17; Net sales - Home Care 16open

Figures in the filing · each found in the filing text

Net sales - Oral Care · Oral, Personal and Home Care · FY202544.0%
Net sales - Personal Care · Oral, Personal and Home Care · FY202517.0%
Net sales - Home Care · Oral, Personal and Home Care · FY202516.0%
Net sales - Pet Nutrition · Pet Nutrition · FY202523.0%
Goodwill and intangible asset impairment charge · Skin Health · Q4-2025$794M
Customer concentration - Walmart · FY202511.0%
Number of employees · 2025-12-3133,600

Risks flagged

Input cost volatility

“Volatility in material and other costs has in the past and may continue to adversely impact our profitability.” · word for word

Tariff and trade policy risk

“Major developments in trade relations, including the imposition of new or increased tariffs...have contributed to and are expected to continue to contribute to inflationary pressures...and have impacted and may continue to impact the cost and/or availability of raw and packaging materials.” · word for word

Geopolitical risk

“We face risks resulting from political and macroeconomic instability and geopolitical events and tensions, wars and military conflicts, such as in Ukraine, the Middle East and Venezuela.” · word for word

Customer concentration risk

“Our sales to Walmart, Inc. and its affiliates represented approximately 11% of our Net sales in 2025.” · word for word

Impairment risk

“in the fourth quarter of 2025, we took a non-cash, aftertax impairment charge of $794 to adjust the carrying values of goodwill and intangible assets related to the skin health business.” · word for word
Read the original on SEC EDGAR ↗
30 Jan 20268-K · 2.02Net Sales $20.38B (+1% y/y); Organic Sales Growth 1.4; GAAP EPS (diluted) $2.63 (-25% y/y); Guidance: Net sales +2-6%, organic +1-4%, double-digit GAAP EPS growth, low-to-mid single-digit Base Business EPS growthearningsopen

Figures in the filing · each found in the filing text

Net Sales · FY2025$20.38B+1% y/y
Organic Sales Growth · FY20251.4%
GAAP EPS (diluted) · FY2025$2.63-25% y/y
Base Business EPS (diluted) · FY2025$3.69+3% y/y
Net Sales · Q4-2025$5.23B+6% y/y
Organic Sales Growth · Q4-20252.2%
GAAP EPS (diluted) · Q4-2025$-0.05-106% y/y
Base Business EPS (diluted) · Q4-2025$0.95+4% y/y
Gross Profit Margin · Q4-202560.2%
Net cash provided by operations · FY2025$4.20B

Guidance

Net sales +2-6%, organic +1-4%, double-digit GAAP EPS growth, low-to-mid single-digit Base Business EPS growth

FY2026 guidance implies continued growth with margin expansion, despite challenging environment.

Risks flagged

Skin health impairment signals weakness in China and category growth; $794M non-cash charge.

“Non-cash, after-tax charge of $794 million to adjust carrying values of goodwill and intangible assets related to the skin health business. Lower than expected category growth rates and weaker than expected performance, particularly in China.” · word for word
Read the original on SEC EDGAR ↗
10 Nov 20258-K · 8.01Aggregate principal amount of senior notes 600,000,000open

Figures in the filing · each found in the filing text

aggregate principal amount of senior notes · Q4-2025$600M
Read the original on SEC EDGAR ↗
31 Oct 20258-K · 2.02, 2.05Net Sales $5.13B (+2% y/y); Organic Sales Growth 0.4; GAAP EPS $0.91 (+1% y/y); Guidance: Organic sales growth guidance cut from 2%-4% to 1%-2%earningsopen

Figures in the filing · each found in the filing text

Net Sales · Total Company · Q3-2025$5.13B+2% y/y
Organic Sales Growth · Total Company · Q3-20250.4%
GAAP EPS · Total Company · Q3-2025$0.91+1% y/y
Base Business Gross profit margin · Total Company · Q3-202559.4%
Net cash provided by operations · Total Company · 9M-2025$2.75B
Global market share toothpaste · Oral Care · YTD-202541.2%
Global market share manual toothbrushes · Oral Care · YTD-202532.4%

Guidance

Organic sales growth guidance cut from 2%-4% to 1%-2%

Organic sales growth guidance cut to 1%-2% from 2%-4%; gross margin guidance lowered; EPS guidance maintained; restructuring program announced

Risks flagged

Slowing category growth in many markets

“slowing category growth in many markets” · word for word

Private label pet exit impacting organic sales by ~70bps

“approximately 70 basis point impact from our exit from private label pet sales” · word for word

Tariff impact included in guidance but uncertain

“including the estimated impact of tariffs announced and finalized as of October 29, 2025” · word for word
Read the original on SEC EDGAR ↗
31 Oct 202510-QColgate-Palmolive reported Q3 2025 results with revenue up 2.0% YoY but volume declined 1.5%, gross margin contracted 190 bps due to raw material cost inflation, and EPS slightly increased to $0.91.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q3-2025$5.13B+2% y/y
Organic sales growth · Q3-20250.4%
Gross profit margin (non-GAAP) · Q3-202559.4%
Operating profit margin (non-GAAP) · Q3-202520.6%
Diluted EPS (GAAP) · Q3-2025$0.91+1% y/y
Net income attributable to Colgate-Palmolive Company (GAAP) · Q3-2025$735M-0% y/y
Operating cash flow · 9M-2025$2.75B-3% y/y
Global toothpaste market share · Oral, Personal and Home Care · YTD-202541.2%
Global manual toothbrush market share · Oral, Personal and Home Care · YTD-202532.4%
Capital expenditures · 9M-2025$387M+3% y/y

Risks flagged

Raw material cost inflation

“This decrease in Gross profit margin was due to significantly higher raw and packaging material costs (600 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (290 bps), higher pricing (90 bps) and favorable mix (30 bps).” · word for word

Volume decline in key regions

“Worldwide Net sales were $5,131 in the third quarter of 2025, up 2.0% from the third quarter of 2024, due to net selling price increases of 2.3% and positive foreign exchange of 1.2%, partially offset by volume declines of 1.5%.” · word for word

Market share loss in toothpaste

“The Company’s share of the global toothpaste market was 41.2% on a year-to-date basis, down 0.5 share points from the year ago period” · word for word

Intangible asset impairment risk

“As of the date of the annual goodwill and indefinite-lived impairment test, the fair value of the skin health reporting unit and one of the Company’s indefinite-lived trademark intangible assets exceeded their carrying values by less than 20%.” · word for word
Read the original on SEC EDGAR ↗

Colgate-Palmolive Company — questions

What did Colgate-Palmolive Company file recently?
13 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-31 — Colgate-Palmolive reported Q2 2026 results with net sales up 4.9% YoY, but GAAP net income down 6.7% due to $129M restructuring charges; non-GAAP EPS up 8%.

Every figure on this page comes from Colgate-Palmolive Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.